Trasciatti; Silvia

Patent Applications and Registrations

Patent applications and USPTO patent grants for Trasciatti; Silvia.The latest application filed is for "cholecalciferol for use in the treatment of celiac disease".

Company Profile

0.7.13

Trasciatti; Silvia - Vecchiano PI
Trasciatti; Silvia - Madonna Dell'Acqua-San Giuliano Terme IT
Trasciatti; Silvia - Ospedaletto IT
TRASCIATTI; Silvia - Ospedaletto It
Trasciatti; Silvia - Pisano IT
Trasciatti; Silvia - San Giuliano Terme IT
Trasciatti, Silvia - Pisa IT

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Cholecalciferol For Use In The Treatment Of Celiac Disease App 20220273676 - Trasciatti; Silvia	2022-09-01
Method for the treatment of osteoarthritis Grant 11,123,354 - Neggiani , et al. September 21, 2	2021-09-21
Xibornol For Use In The Treatment Of Acne Vulgaris App 20200155478 - Trasciatti; Silvia	2020-05-21
Pharmaceutical Formulation For The Treatment Of Osteoarthritis Containing Clodronic Acid And Hyaluronic Acid App 20200147126 - ROSINI; Sergio ; et al.	2020-05-14
Composition For The Treatment Of Osteoarthritis App 20200061088 - Neggiani; Fabio ; et al.	2020-02-27
Pharmaceutical Formulation For The Treatment Of Osteoarthritis Containing Clodronic Acid And Hyaluronic Acid App 20180185407 - ROSINI; Sergio ; et al.	2018-07-05
Pharmaceutical formulation for the treatment of osteoarthritis containing clodronic acid and hyaluronic acid Grant 9,943,540 - Rosini , et al. April 17, 2	2018-04-17
Pharmaceutical Formulation For The Treatment Of Osteoarthritis Containing Clodronic Acid And Hyaluronic Acid App 20140371170 - ROSINI; Sergio ; et al.	2014-12-18
Cyclic hydroxylamine as psychoactive compounds App 20120015947 - Parsons; Phillip ; et al.	2012-01-19
Cyclic hydroxylamine as psychoactive compounds Grant 8,053,432 - Parsons , et al. November 8, 2	2011-11-08
Cyclic hydroxylamine as psychoactive compounds Grant 7,842,689 - Parsons , et al. November 30, 2	2010-11-30
Cyclic hydroxylamine as psychoactive compounds Grant 7,842,690 - Parsons , et al. November 30, 2	2010-11-30
Cyclic hydroxylamine as psychoactive compounds App 20100256150 - Parsons; Phillip ; et al.	2010-10-07
Procedure for the large-scale T-lymphocytes culture in a homogeneous system Grant 7,678,571 - Trasciatti , et al. March 16, 2	2010-03-16
Cyclic hydroxylamine as psychoactive compounds App 20090312329 - Parsons; Phillip ; et al.	2009-12-17
Pharmaceutical Formulation For The Treatment Of Osteoarthritis Containing Clodronic Acid And Hyaluronic Acid App 20090042833 - Rosini; Sergio ; et al.	2009-02-12
Cyclic hydroxylamine as psychoactive compounds App 20060142286 - Parsons; Phillip ; et al.	2006-06-29
Procedure for the large-scale t-lymphocytes culture in a homogeneous system App 20060034802 - Trasciatti; Silvia ; et al.	2006-02-16
Osteogenic growth oligopeptides as stimulants of hematopoiesis App 20050004037 - Bab, Itai ; et al.	2005-01-06
Catalytic monoclonal antibodies with protease activity for selective lysis of protein component of plaques aggregates pathological conditions Grant 6,387,674 - Trasciatti , et al. May 14, 2	2002-05-14

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.